Not only was increased GnRHR-AAb activity observed, along with the expected inhibitory effect of cetrorelix, in the PCOS group, but a statistically significant correlation was also found between GnRHR-AAb activity and both testosterone and proinflammatory cytokines. This evidence concerns the gene GNRHR and polycystic ovary syndrome.